印度制药公司Reddy博士因在墨西哥违反进口准则而被罚款;股票下跌。 Indian pharma firm Dr. Reddy's fined for import guideline breaches in Mexico; shares dip.

印度制药公司Reddy博士的实验室因未遵守产品进口准则而被墨西哥药物监管机构罚款27万卢比。 Indian pharmaceutical company Dr. Reddy's Laboratories has been fined 27 lakh rupees by Mexico's drug regulator for failing to follow guidelines in importing a product. 发票日期错误以及参考标准名称和进口许可证之间的差异导致罚款。 Errors in the invoice date and discrepancies between the reference standard name and the import license led to the fine. 在宣布之后,Reddy博士的股份在孟买股票交易所每股下跌0.70 %至1 237卢比。 Following the announcement, Dr. Reddy's shares dropped 0.70% to 1,237 rupees per share on the Bombay Stock Exchange.